Tilfrinib

Ref. 3D-APC51549

Informations sur le produit

• Nom: Tilfrinib
• Marque: Biosynth
• Description: Tilfrinib is a drug that binds to the epidermal growth factor receptor (EGFR) and inhibits its kinase activity. It is an anti-EGFR antibody conjugate or immunoconjugate that is used for the treatment of cancers. The drug contains an antibody that binds to EGFR, which is linked to a cytotoxic agent such as a small molecule, toxin, or radioisotope. Tilfrinib has been shown to be effective in treating cancers with mutations in the EGFR gene.

Propriétés chimiques

• Masse moléculaire: 275.3 g/mol
• Formule: C₁₇H₁₃N₃O
• Degré de pureté: Min. 95%